{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:48:00Z","timestamp":1782841680745,"version":"3.54.5"},"reference-count":26,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Negative symptoms (NS) such as anhedonia (reduced pleasure), avolition (reduced motivation), asociality (social withdrawal), blunted affect (diminished emotional expression), and alogia (poverty of speech) are associated with poor functional outcomes in psychiatric and neurological disorders and are an unmet treatment need. Current medication primarily targets positive or affective symptoms, leaving NS neurobiology unaddressed. A critical research gap exists in understanding whether these symptoms share a common biological architecture across different diagnoses or whether they emerge from distinct pathological pathways.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This observational, single-center study aims to characterize NS across a transdiagnostic sample of individuals with mental disorders and related conditions, with a particular focus on avolition, its biological correlates, and associated neurocognitive and electrophysiological profiles and the aim of determining whether particular NS consistently occupy central positions across disorders or centrality patterns differ by diagnosis. By linking these symptom profiles to underlying neurocognitive, electrophysiological, and genetic markers, the study seeks to disentangle shared versus disorder-specific mechanisms.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In total, 300 participants with a primary diagnosis of schizophrenia, bipolar disorder, unipolar depressive disorder, autism, or dementia will be recruited, with a target of at least 50 individuals in each diagnostic group. Over a 4-day schedule, participants will undergo clinical (Brief Negative Symptom Scale, Positive and Negative Syndrome Scale, Hamilton Depression Rating Scale, Personal and Social Performance Scale, Udvalg for Kliniske Unders\u00f8gelser Side Effect Rating Scale, and Barnes Akathisia Rating Scale), neurocognitive (Brief Assessment of Cognition in Schizophrenia, and Temporal Experience of Pleasure Scale), and biological (resting-state electroencephalography and blood sampling for polygenic risk score) assessments. Network analysis will compute symptom centrality to determine if avolition acts as a transdiagnostic hub. Structural equation modeling will link network profiles to neurophysiological and genetic data. This methodology is designed to identify convergent biological markers, clarify avolition\u2019s role in symptom heterogeneity, and refine understanding of NS as multidimensional phenomena beyond traditional diagnostic boundaries.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The initial version of the study protocol was developed in February 2024. The finalized protocol was completed on May 8, 2024, and updated on January 11, 2025, to incorporate minor methodological clarifications. Participant recruitment and data collection commenced on July 1, 2024, and are ongoing at the time of manuscript submission. By March 2026, the study had enrolled 286 participants. Data quality control and preliminary analyses are performed concurrently with data collection. Final statistical analyses and dissemination of results are planned following completion of the recruitment phase.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study will provide critical insights into the characterization and underlying mechanisms of NS across psychiatric disorders. By focusing on avolition, reward processing, and their interaction with neurocognitive and social cognitive deficits, it will help identify potential biological and electrophysiological markers of NS. The findings may guide the development of more precise assessment tools and inform novel therapeutic strategies, with broad translational impact for improving outcomes in individuals with serious mental illnesses and related conditions.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/92115","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:00:09Z","timestamp":1774890009000},"page":"e92115-e92115","source":"Crossref","is-referenced-by-count":0,"title":["Modeling Negative Symptom Domain Neurobiology: Protocol for an Observational, Transdiagnostic, Translational Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3885-782X","authenticated-orcid":false,"given":"Dan C\u0103t\u0103lin","family":"Oprea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9832-8475","authenticated-orcid":false,"given":"Ilinca","family":"Untu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8591-6602","authenticated-orcid":false,"given":"Diana-Sabina","family":"Vieru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6506-8831","authenticated-orcid":false,"given":"Camelia","family":"Dasc\u0103lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-6102","authenticated-orcid":false,"given":"Helene","family":"Speyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0064-7344","authenticated-orcid":false,"given":"Cristina","family":"Dobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7436-7695","authenticated-orcid":false,"given":"Ohad","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3023-0205","authenticated-orcid":false,"given":"Romeo Petru","family":"Dobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-1719","authenticated-orcid":false,"given":"Michael","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6845-8064","authenticated-orcid":false,"given":"Jonathan","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9868-1999","authenticated-orcid":false,"given":"Bogdan Ionel","family":"Tamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"2","key":"R1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"R2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","journal-title":"PLoS Med"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195687","article-title":"Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses","volume":"13","author":"Moreno-K\u00fcstner","journal-title":"PLoS One"},{"issue":"10053","key":"R4","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","journal-title":"Lancet"},{"issue":"8","key":"R5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S2215-0366(18)30050-6","article-title":"Negative symptoms of schizophrenia: new developments and unanswered research questions","volume":"5","author":"Galderisi","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.31887\/DCNS.2015.17.1\/phoff","article-title":"The Kraepelinian tradition","volume":"17","author":"Hoff","journal-title":"Dialogues Clin Neurosci"},{"issue":"6","key":"R7","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1037\/rev0000515","article-title":"Advancing the network theory of mental disorders: a computational model of panic disorder","volume":"131","author":"Robinaugh","journal-title":"Psychol Rev"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00145-4","article-title":"Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development","volume":"7","author":"Strauss","journal-title":"NPJ Schizophr"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/schbul\/sbz141","article-title":"Network analysis indicates that avolition is the most central domain for the successful treatment of negative symptoms: evidence from the roluperidone randomized clinical trial","volume":"46","author":"Strauss","journal-title":"Schizophr Bull"},{"issue":"2","key":"R10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","journal-title":"Schizophr Bull"},{"key":"R11","unstructured":"Cohen J . Statistical Power Analysis for the Behavioral Sciences. Routledge; 1988."},{"issue":"1","key":"R12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/0049124187016001004","article-title":"Practical issues in structural modeling","volume":"16","author":"Bentler","journal-title":"Sociol Methods Res"},{"key":"R13","unstructured":"Kline RB . Principles and Practice of Structural Equation Modeling. 4th ed. Guilford Press; 2016."},{"issue":"2","key":"R14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1037\/1082-989X.1.2.130","article-title":"Power analysis and determination of sample size for covariance structure modeling","volume":"1","author":"MacCallum","journal-title":"Psychol Methods"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-023-00380-x","article-title":"The Brief Negative Symptom Scale (BNSS): a systematic review of measurement properties","volume":"9","author":"Weigel","journal-title":"Schizophrenia (Heidelb)"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Dang NN Tran X Mai A Vi CT . Unveiling mental health states through multi-modal AI integration with EEG signals: a systematic review. In: Vo VT Nguyen TH Vong BL Pham TT Doan NH , editors. 10th International Conference on the Development of Biomedical Engineering in Vietnam. Springer; 2025:523-536. [doi: 10.1007\/978-3-031-90197-3_40]","DOI":"10.1007\/978-3-031-90197-3_40"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1037\/met0000764","article-title":"Estimating causal effects on psychological networks using item response theory","volume":"31","author":"Gilbert","journal-title":"Psychol Methods"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3758\/s13428-017-0862-1","article-title":"Estimating psychological networks and their accuracy: a tutorial paper","volume":"50","author":"Epskamp","journal-title":"Behav Res Methods"},{"issue":"5","key":"R20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/schbul\/sbq068","article-title":"Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions","volume":"36","author":"Barch","journal-title":"Schizophr Bull"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/wps.20607","article-title":"Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP)","volume":"18","author":"Reininghaus","journal-title":"World Psychiatry"},{"issue":"2","key":"R22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/archgenpsychiatry.2011.1269","article-title":"Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence","volume":"69","author":"Gold","journal-title":"Arch Gen Psychiatry"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2014.06.058","article-title":"Reward dysfunction in major depression: multimodal neuroimaging evidence for refining the melancholic phenotype","volume":"101","author":"Foti","journal-title":"Neuroimage"},{"issue":"2","key":"R24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biopsych.2018.12.015","article-title":"Predicting polygenic risk of psychiatric disorders","volume":"86","author":"Martin","journal-title":"Biol Psychiatry"},{"issue":"2","key":"R25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/schbul\/sbn094","article-title":"Negative symptoms in schizophrenia: avolition and Occam\u2019s razor","volume":"36","author":"Foussias","journal-title":"Schizophr Bull"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114926","article-title":"A narrative review of treatment interventions to improve cognitive performance in schizophrenia, with an emphasis on at-risk and early course stages","volume":"317","author":"Mayeli","journal-title":"Psychiatry Res"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e92115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:15:52Z","timestamp":1782839752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e92115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2196\/92115","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"v15i2e92115"}}